D-0804-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- May 4, 2022
- Initiation Date
- April 4, 2022
- Termination Date
- June 17, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4129 vials
Product Description
T-106, Papaverine 30 mg/mL . Phentolamine 1 mg/mL . Alprostadil 25 mcg/mL, Packaged as a) 10 mL Multi-Dose vial, NDC: 73198-0013-10; b) 5 mL Multi-Dose vial, NDC 73198-0013-05; Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835.
Reason for Recall
CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Distribution Pattern
Distributed Nationwide in the USA
Code Information
Lots: a) E24510 BUD: 5/10/2022, E24610 BUD: 5/10/2022; b) H42H03 BUD: 8/3/2022, E24810 BUD: 5/10/2022, H42203 BUD: 8/3/2022